Abstract
The problem of prevention and therapy of allergic reactions to drugs is complex and not yet satisfactorily resolved. Measures to reduce the incidence of allergic reactions to drugs may be taken at several levels, for instance by the manufacturer, the treating physician, or the patient himself.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Agrup G (1972) Patch testing in drug allergy. In: Dash CH, Jones HEH (eds) Mechanisms of drug allergy. Churchill-Livingstone, Edinburgh/london, p 135
Ahlstedt S, Ekstroem B, Svaerd PO, Sjoeberg B, Kristofferson A, Oertengren B (1980) New aspects on antigens in penicillin allergy. CRC Crit Rev Toxicol 7:219
Amkraut AA, Rosenberg LT, Raffel S (1963) Elicitation of PCA by univalent and divalent haptens. J Immunol 91:644
Basomba A, Pelaez A, Villalmanzo IG, Campos A (1978) Allergy to penicillin unsuccessfully treated with a haptenic inhibitor (Benzylpenicilloyl-N-formyllysine: BPO-Flys). A case report. Clin Allergy 8:341
Batchelor FR, Dewdney JM, Feinberg JG, Weston RD (1967) A penicilloylated protein impurity as a source of allergy to benzylpenicillin and 6-amino-penicillanic acid. Lancet 1:1175
Borel Y, Kilham L, Hyslop N, Borel H (1976) Isologous IgG-induced tolerance to benzyl-penicilloyl. Nature 261:49
Bundgaard H, de Weck AL (1975) The role of aminoreactive impurities in acetylsalicylic acid allergy. Int. Arch. Allergy Appl. Immunol 49:119
Chase MW (1946) Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Bio Med 61:257
Chiorazzi N, Eshhar Z, Katz DH (1976) Induction of immunological tolerance to the major antigenic determinant of penicillin: a therapeutic approach to penicillin allergy, Proc Natl Acad Sci USA 72:2091
Coutinho A, Moeller G, Richter W (1974) Molecular basis of B cell activation. I. Mitogenicity of native and substitutes dextrans. Scand J Immunol 3:321
De Weck AL (1975) Molecular mechanisms of T and B lymphocyte triggering. Int Arch Allergy Appl Immunol 49:247
De Weck AL (1977 a) Drug reactions. In: Samter M (ed) Immunological diseases, 2nd ed. Little, Brown & Co., Boston, p 415
De Weck AL (1977 b) Immune responses to environmental antigens which act on the skin (which special reference to the role of lymphokines in contact dermatitis). Fed Proc 36:1742
De Weck AL (1978) Application du RAST dans l’allergie à la pénicilline. Med Hyg 36:118
De Weck AL, Eisen HN (1960) Some immunochemical properties of penicillenic acid, an antigenic determinant derived from penicillin. J Exp Med 112:1227
De Weck AL, Girard JP (1972) Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten: II. Clinical studies. Int Arch Allergy Appl Immunol 42:798
De Weck AL, Schneider CH (1972) Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten: I. Experimental immunological and toxicologic studies. Int Arch Allergy 42:789
De Weck AL, Schneider H (1980) Allergic and immunological aspects of therapy with cefotaxine and other cephalosporins. J Antimicrob Chemother 6:161
De Weck AL, Schneider CH, Gutersohn J (1968) The role of penicilloylated protein impurities, penicillin polymers and dimers in penicillin allergy. Int Arch Allergy Appl Immunol 33:535
De Weck AL, Schneider CH, Toffler O, Lazary S (1973) Inhibition of allergic reactions by monovalent haptens. In: Sehon A (ed) Mechanisms of reaginic allergy. Dekker, New York, p 323
De Weck AL, Jeunet F, Schulz KH, Louis P, Girard JP, Grilliat JP, Moneret-Vautrin D et al. (1975) Clinical trial of Ro 6–0787: a monovalent specific hapten inhibitor of penicillin allergy. Z. Immunitätsforsch 150:138
De Weck AL, Toffler O, Koleckarova M, Spengler M (1976) Theoretical basis and experimental studies on the prevention of allergic reactions to penicillins by a monovalent benzylpenicilloyl hapten. Chemotherapy 4:345
Dewdney J (1977) Immunology of the antibiotics. In: Sela M (ed) The antigens, IV. Academic Press, New York, p 74
Farah FS, Kern M, Eisen HN (1960) Specific inhibition of wheal-and-erythema responses with univalent haptens and univalent antibody fragments. J Exp Med 112:1211
Felix RH, Comaish JS (1974) The value of patch and other skin tests in drug eruptions. Lancet 1:1017
Frick OL, Nye W, Raffel S (1968) Anaphylactic reactions to univalent haptens. Immunology 14:563
Gorevic PD, Levine BB (1981) Desensitization of anaphylactic hypersensitivity specific for the penicilloate minor determinant of penicillin and carbenicillin. J Allergy clin Immunol 68:267
Green I, Paul WE, Benacerraf B (1966) The behavior of hapten-poly-L-lysine conjugates as complete antigens in genetic responders and as haptens in nonresponder guinea pigs. J Exp Med 123:859
Grieco MH, Dubin MR, Robinson JL, Schwartz MJ (1964) Penicillin hypersensitivity in patients with bacterial endocarditis. Ann Intern Med 60:204
Howard JG, Mitchison NA (1975) Immunological tolerance. Prog Allergy 18:43
Katz DH, Hamaoka R, Benacerraf B (1972) Immunological tolerance in bone marrow derived lymphocytes. I. Evidence for an intracellular mechanism of inactivation of hapten-specific precursors of antibody-forming cells. J Exp Med 136:1404
Klein U, Gikalov I, Keller M, Hoigné R (1972) “Drug monitoring” in der medizinischen Abteilung eines Regionalspitals. Schweiz Med Wochenschr 102:1083
Kraft D, Roth A, Mischer P, Pichler H, Ebner H (1977) Specific and total serum IgE measurements in the diagnosis of penicillin allergy. A long term follow-up study. Clin Allergy 7:21
Kristofferson A, Ahlstedt A, Pettersson E, Svaerd PO (1977) Antigens in penicillin allergy. I. A radioimmunoassay for detection of penicilloylated protein contaminants in penicillin preparations. Int Arch Allergy Appl Immunol 55:13
Lee WY, Sehon AH (1975) Suppression of reaginic antibody formation II. The use of adoptive transfer system for the study of immunological unresponsiveness. J Immunol 114:837
Lee WY, Sehon AH (1976) Suppression of reaginic antibody formation IV. Suppression of reaginic antibodies to penicillin in the mouse. J Immunol 117:927
Lee WY, Hubbard BA, Gripps V, Sehon AH (1980) Abrogation of the antibenzylpenicilloyl (BPO) IgE Response with BPO-polyvinyl alcohol conjugates. Int Arch Allergy Appl Immunol 63:1
Levine BB (1966) Immunochemical mechanisms of drug allergy. Ann Rev Med 17:23
Magnusson B, Kligman AM (1970) Allergic contact dermatitis in the guinea pig. Thomas, Springfield, Ill
Mattson JR, Patterson R, Roberts M (1975) Insulin therapy in patients with systemic insulin allergy. Arch Intern Med 135:818
Mitchell GF, Humphrey JH, Williamson AR (1972) B cell tolerance induced by polymeric antigens I. Comparison of the dose and epitope density requirements for inactivation of primed and unprimed B cells in vivo. Eur J Immunol 5:361
Mota I (1964) The mechanism of anaphylaxis I. Production and biological properties of “mast cell sensitizing” antibody. Immunology 7:681
Neftel KA„ Waelti M„ Spengler H„ Von Feiten A„ Weitzman SA„ Buergi H„ de Weck AL (1981) Neutropenia after penicillins: Toxic or immune-mediated? Klin Wochenschr 59:877
Otz U, Schneider CH, de Weck AL, Gruden E, Gill TG (1978) Induction of immunological tolerance to the penicilloyl antigenic determinant I. Evaluation of BPO-amino acid polymers and copolymers in mice. Eur J Immunol 8:406
Ovary Z, Karush F (1960) Studies on the immunologic mechanism of anaphylaxis: I. Anti-body-hapten interactions studied by passive cutaneous anaphylaxis in the guinea pig. J Immunol 84:409
Paley RS, Leskowitz S, Borel Y (1975) Effect on tolerance induction of the mode of attachment of the hapten to the carrier. J Immunol 115:1409
Parker CW (1980) Drug Allergy. In: Parker CW (ed) Clinical immunology. Saunders, Philadelphia p 1219
Reismann RE, Rose NR, Witebsky E, Arbesman C (1962) Penicillin allergy and desensiti-zation. J Allergy Clin Immunol 33:178
Ruegger R, Spengler H, de Weck AL, Dubach UC (1973) Immunologische Aspekte der Sensibilisierung auf Phenacetin. Dtsch Med Wochenschr 98:762
Sawrat JH, Ponvert C, Burtin C, Soubrane C, Bender F, Paupe I (1976) Lymphocyte transformation, leukocyte migration, specific IgE, IgG, and IgM before, during and after penicillin treatment without adverse reaction. Acta Allergol 31:1
Schneider CH, Otz U, Gruden E (1978) Induction of immunological tolerance to the penicilloyl antigenic determinant II. Evaluation of stable and unstable penicilloyl-dextrans. Eur J Immunol 8:410
Schneider CH, Gruden E, Waelti M, Toffler O, de Weck AL, Jost R (1979) Monovalent elicitation of passive cutaneous anaphylaxis by N-1-DNCP-N-6-BPO-diaminohexane. Mol Immunol 16:269
Sullivan TJ, Wedner JH, Skatz GS, Yiecies LD, Parker CW (1981) Skin test to detect penicillin allergy. J Allergy Clin Immunol 68. 171
Van Arsdel PP Jr (1978) Adverse drug reactions. In: Middleton E Jr, Read CE, Ellis EF (eds). Allergy: principles and practice, Mosby, St. Louis, vol 2. pp 1133
Wide L, Juhlin L (1971) Detection of penicillin allergy of the immediate-type by radio-immunoassay of reagins (IgE) to penicilloyl conjugates. Clin Allergy 1:171
Zolov D, Redmond AP, Levine BB (1967) Immunological studies of desensitization in penicillin allergy. J Allergy Clin Immunol 39:107
Zweiman B, Mishkin MM, Hildreth EA (1975) An approach to the performance of contrast studies in contrast material reactive persons. Ann Intern Med 83:159
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
De Weck, A.L. (1983). Prevention and Treatment of Drug Allergies. In: de Weck, A.L., Bundgaard, H. (eds) Allergic Reactions to Drugs. Handbook of Experimental Pharmacology, vol 63. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69088-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-69088-4_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69090-7
Online ISBN: 978-3-642-69088-4
eBook Packages: Springer Book Archive